George Varigos, Holly Anderton, Najoua Lalaoui, Walter and Eliza Hall Institute (IMAGE)
Caption
Existing medicines could offer a new way to treat inflammatory skin conditions, researchers at the Walter and Eliza Hall Institute and the Royal Melbourne Hospital in Melbourne, Australia, have revealed. The research team discovered skin inflammation relies on a protein called RIPK1, and could be prevented by depleting this protein. The finding offers hope that drugs targeting RIPK1, which are currently in clinical trials, could offer relief to people with skin conditions such as psoriasis. The research team (from left): Royal Melbourne Hospital dermatologist Professor George Varigos with Ms Holly Anderton and Dr Najoua Lalaoui from the Walter and Eliza Hall Institute
Credit
Walter and Eliza Hall Institute
Usage Restrictions
None
License
Licensed content